Brand profile · Biotechnology Research

Respirion Pharmaceuticals Pty Ltd

Respirion Pharmaceuticals Pty Ltd is a Biotechnology Research brand in Perth, Western Australia. Privately held, at respirionpharma.com. It holds one address on record, all in Australia. It employs 5 people, on the record. It lists cystic Fibrosis, non-CF bronchiectasis and inhaled therapeutics among its specialties. One Australian registration (ABN) is a confirmed match. It is listed alongside three similar brands, mostly in Venture Capital and Private Equity Principals.

Profile live Privately Held Founded 2018 1 entity ABN 1 office country
Registry verified · ABR

Key facts

Counted staff
5
self-reported 2–10 band
Founded
2018
8 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • RESPIRION PHARMACEUTICALS PTY LTD

    ABN49623568409

    WAHigh confidenceMatched on exact nameABR

Legal entities

Respirion Pharmaceuticals Pty Ltd: 1 registry entityRespirion Pharmaceuticals Pty Ltd is linked to 1 registry entity: RESPIRION PHARMACEUTICALS PTY LTD (ABN 49623568409, candidate).Respirion Pharmaceuticals Pty LtdRESPIRIONPHARMACEUTICALS PTY LTDABN 49623568409Candidate · High confidence
Show as table · Respirion Pharmaceuticals Pty Ltd: 1 registry entity
Respirion Pharmaceuticals Pty Ltd: 1 registry entity
RESPIRION PHARMACEUTICALS PTY LTDABN 49623568409
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory disease. The Company is a spinout from the Telethon Kids Institute in Perth where the product development was incubated.

Respirion’s lead product, an inhaled therapy for the life-threatening disease Cystic Fibrosis, has shown promising results in an early clinical study carried out with the Western Australian Department of Health.

Respirion is currently conducting a Phase 1b/2a clinical study in the US and Australia (NCT06016088 and ANZCTR registered) to evaluate the safety and efficacy of its proprietary antibiotic combination for the treatment of lung infections in people with Cystic Fibrosis.

Specialties

All 5 specialties
  • Cystic Fibrosis
  • non-CF bronchiectasis
  • inhaled therapeutics
  • antibiotics
  • iron chelators

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country. Codes: AU.1 countryAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1

All codes: AU

Addresses

  • AUPerth, Western Australia 6028

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Respirion Pharmaceuticals Pty Ltd?

One Western Australia entity on the ABR: RESPIRION PHARMACEUTICALS PTY LTD (ABN 49 623 568 409), high confidence.

How many people work at Respirion Pharmaceuticals Pty Ltd?

5 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Respirion Pharmaceuticals Pty Ltd have offices?

One address on record, Australia only.

Has Respirion Pharmaceuticals Pty Ltd raised funding?

None linked to this brand.

What does Respirion Pharmaceuticals Pty Ltd list as its specialties?

Five tags on the brand's own list, among them Cystic Fibrosis, non-CF bronchiectasis and inhaled therapeutics.

Which companies are listed alongside Respirion Pharmaceuticals Pty Ltd?

4 profiles list Respirion Pharmaceuticals Pty Ltd as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. ENA Respiratory lists it back.

What is Respirion Pharmaceuticals Pty Ltd's website?